Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP

Liminal BioSciences minority shareholders to receive US$8.50 in cash per share in “go private” transaction LAVAL, QC, CAMBRIDGE, England, and TORONTO, July 12, 2023 /PRNewswire/ — Liminal BioSciences Inc. (“Liminal BioSciences” or the “Company”) (NASDAQ: LMNL) and Structured Alpha LP…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.